| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 351 |
| 1 | INFLIXIMAB | 225 |
| 2 | PREDNISONE | 196 |
| 3 | VEDOLIZUMAB | 163 |
| 4 | USTEKINUMAB | 116 |
| 5 | AZATHIOPRINE | 104 |
| 6 | CIPROFLOXACIN HYDROCHLORIDE | 104 |
| 7 | METRONIDAZOLE | 100 |
| 8 | CIPROFLOXACIN | 99 |
| 9 | INFLIXIMAB-DYYB | 94 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | METHACHOLINE CHLORIDE | 2 | 0.0286 |
| 1 | INFLIXIMAB-DYYB | 94 | 0.0273 |
| 2 | DIBUCAINE 1% | 1 | 0.0087 |
| 3 | SODIUM HYPOCHLORITE | 2 | 0.0077 |
| 4 | LOPERAMIDE HCI | 1 | 0.0068 |
| 5 | PRUCALOPRIDE SUCCINATE | 2 | 0.0057 |
| 6 | LACTIC ACID, L-, CITRIC ACID MONOHYDRATE, AND POTASSIUM BITARTRATE | 1 | 0.0055 |
| 7 | ANORECTAL OINTMENT | 1 | 0.0046 |
| 8 | BENZOCAINE AND DEXTROMETHORPHAN HYDROBROMIDE | 1 | 0.0040 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 18 | 0.0040 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 424 |
| 1 | Corticosteroid [EPC] | 321 |
| 2 | Integrin Receptor Antagonist [EPC] | 181 |
| 3 | Interleukin-23 Antagonist [EPC] | 152 |
| 4 | Nonsteroidal Anti-inflammatory Drug [EPC] | 136 |
| 5 | Interleukin-12 Antagonist [EPC] | 116 |
| 6 | Purine Antimetabolite [EPC] | 104 |
| 7 | Nitroimidazole Antimicrobial [EPC] | 100 |
| 8 | Aminosalicylate [EPC] | 95 |
| 9 | Folate Analog Metabolic Inhibitor [EPC] | 85 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 16 | 0.0027 |
| 1 | Provitamin D2 Compound [EPC] | 75 | 0.0025 |
| 2 | Integrin Receptor Antagonist [EPC] | 181 | 0.0021 |
| 3 | Nitroimidazole Antimicrobial [EPC] | 100 | 0.0015 |
| 4 | Interleukin-23 Antagonist [EPC] | 152 | 0.0015 |
| 5 | Interferon gamma [EPC] | 2 | 0.0014 |
| 6 | beta Lactamase Inhibitor [EPC] | 5 | 0.0011 |
| 7 | Interleukin-12 Antagonist [EPC] | 116 | 0.0011 |
| 8 | Purine Antimetabolite [EPC] | 104 | 0.0011 |
| 9 | Opioid Antagonist [EPC] | 1 | 0.0010 |